Private Equity in False Claims Act Cases

Private equity firms are having more control and influence in the health care industry. But with that trend comes more risk.

In this latest installment of our “Spotlight: White Collar” series, partner Giselle Joffre delves into the trend of private equity firms being named as defendants in False Claims Act cases.

Our “Spotlight: White Collar” series features our white collar attorneys discussing a broad range of subject matter expertise--from financial regulation to cryptocurrency, government contracts to national security, and life sciences to environmental law. You’ll hear about experiences at every stage of the legal process—internal and external investigations, trials, dawn raids, compliance programs, regulatory access, and everything that comes up along the way. 

Watch the rest of the “Spotlight: White Collar” series here.